Shield Therapeutics PLC Aktie
Finanztrends
Deine Einschätzung
Shield Therapeutics PLC Aktie
Konstante Performance: Der Shield Therapeutics PLC Kurs bleibt auf dem gleichen Niveau.
Was spricht für und gegen Shield Therapeutics PLC in den nächsten Jahren?
Pro
?
A****************
?
U****************
?
M************
Kontra
?
W******* i* V********
?
L*********** I********** f** d** n******* J****
?
M****
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Shield Therapeutics PLC im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Shield Therapeutics PLC | 0,00 % | 0,00 % | -21,02 % | 129,63 % | -40,95 % | -13,89 % | -90,75 % |
| Card Factory plc | -1,68 % | -4,81 % | -3,91 % | -35,15 % | -6,32 % | -33,08 % | -10,44 % |
| Pets At Home Group Ls 1 | -0,56 % | -2,44 % | 1,50 % | -33,44 % | -5,84 % | -52,00 % | -57,61 % |
| Natural Grocers By Vit. Cot. | 0,81 % | -2,38 % | 0,82 % | -39,11 % | 14,95 % | 148,48 % | 158,95 % |
Kommentare
News
Exagen Q1 Earnings Call Highlights
Exagen (NASDAQ:XGN) reported record first-quarter revenue and reaffirmed its full-year outlook, as executives said growth in testing volume, improved reimbursement execution and expanding clinician
What Is the "Achilles Shield" and How Is Lockheed Martin Involved? Here's What Investors Need to Know.
Greece's air-defense capabilities will soon be getting an upgrade. That's the chief takeaway from the country's recent vote by the Special Permanent Parliamentary Committee on Armaments Programs and
5 Stocks and ETFs to Help Shield Your Portfolio During Volatility
The U.S. stock market has gotten off to an unsteady start this year. Outside a handful of defensive pockets, such as consumer staples and energy, most investors have felt the pressure. Elevated